Author: Najim, Mostafa; Rahhal, Alaa; Khir, Fadi; Aljundi, Amer Hussien; Abu Yousef, Safae; Ibrahim, Feryal; Amer, Aliaa; Mohamed, Ahmed S.; Saleh, Samira; Alfaridi, Dekra; Mahfouz, Ahmed; Alyafei, Sumaya; Howady, Faraj; Khatib, Mohamad; Alemadi, Samar A.
Title: Prevalence and clinical significance of antiphospholipid antibodies in patients with coronavirus disease 2019 admitted to intensive care units: a prospective observational study Cord-id: t2gn3a9r Document date: 2021_5_5
ID: t2gn3a9r
Snippet: Coronavirus disease 2019 (COVID-19) increases the risk of coagulopathy. Although the presence of antiphospholipid antibodies (aPLs) has been proposed as a possible mechanism of COVID-19-induced coagulopathy, its clinical significance remains uncertain. Therefore, this study aimed to evaluate the prevalence and clinical significance of aPLs among critically ill patients with COVID-19. This prospective observational study included 60 patients with COVID-19 admitted to intensive care units (ICU). T
Document: Coronavirus disease 2019 (COVID-19) increases the risk of coagulopathy. Although the presence of antiphospholipid antibodies (aPLs) has been proposed as a possible mechanism of COVID-19-induced coagulopathy, its clinical significance remains uncertain. Therefore, this study aimed to evaluate the prevalence and clinical significance of aPLs among critically ill patients with COVID-19. This prospective observational study included 60 patients with COVID-19 admitted to intensive care units (ICU). The study outcomes included prevalence of aPLs, and a primary composite outcome of all-cause mortality and arterial or venous thrombosis between antiphospholipid-positive and antiphospholipid-negative patients during their ICU stay. Multiple logistic regression was used to assess the influence of aPLs on the primary composite outcome of mortality and thrombosis. A total of 60 critically ill patients were enrolled. Among them, 57 (95%) were men, with a mean age of 52.8 ± 12.2 years, and the majority were from Asia (68%). Twenty-two patients (37%) were found be antiphospholipid-positive; 21 of them were positive for lupus anticoagulant, whereas one patient was positive for anti-β2-glycoprotein IgG/IgM. The composite outcome of mortality and thrombosis during their ICU stay did not differ between antiphospholipid-positive and antiphospholipid-negative patients (4 [18%] vs. 6 [16%], adjusted odds ratio 0.98, 95% confidence interval 0.1–6.7; p value = 0.986). The presence of aPLs does not seem to affect the outcomes of critically ill patients with COVID-19 in terms of all-cause mortality and thrombosis. Therefore, clinicians may not screen critically ill patients with COVID-19 for aPLs unless deemed clinically appropriate.
Search related documents:
Co phrase search for related documents- active bleeding and acute respiratory distress syndrome: 1, 2
- active bleeding and acute respiratory distress syndrome icu admission: 1
- active bleeding and local protocol: 1
- active malignancy and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6
- active malignancy and acute respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7
- active malignancy and local protocol: 1
- active malignancy and logistic regression: 1, 2, 3, 4
- acute ards respiratory distress syndrome and additional analysis: 1, 2, 3
- acute ards respiratory distress syndrome and adjusted care unit: 1, 2, 3, 4
- acute ards respiratory distress syndrome and liver enzyme: 1, 2, 3, 4
- acute ards respiratory distress syndrome and local protocol: 1, 2, 3
- acute ards respiratory distress syndrome and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute phase and additional analysis: 1
- acute phase and liver enzyme: 1, 2
- acute phase and local protocol: 1
- acute phase and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory distress syndrome and adjusted care unit: 1, 2, 3, 4
- acute respiratory distress syndrome and liver enzyme: 1, 2, 3, 4, 5, 6
- acute respiratory distress syndrome and local protocol: 1, 2, 3, 4, 5
Co phrase search for related documents, hyperlinks ordered by date